Michael Kratsios: Pax Silica is a broader alliance focused on supply chain challenges that the United States and many partner nations have faced. It is a small, select group of countries working ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

The company this week announced it has broken ground on the second data center at its Inzai campus, adding a standalone 18MW building to the existing 18MW facility. Delivery of TKYO1B is expected in ...

Chicopee - Elms College announces the launch of its Master’s Degree in Data Analytics & AI, a dynamic new graduate program designed to prepare students for careers in rapidly growing fields such as ...

Spire Global has won contracts to provide the National Oceanic and Atmospheric Administration's Commercial Weather Data Program with global navigation satellite system (GNSS) radio occultation and ...

SAN FRANCISCO--(BUSINESS WIRE)--ClickHouse, Inc., the company behind the world’s fastest real-time analytical database, announced a high-performance, enterprise-grade Postgres service natively ...

This story has been updated to include comments from STACK Infrastructure and Commissioner Greg Young. A global data center developer with a growing footprint across the United States is tied to ...

A global data center developer is linked to large land purchases in Caddo and Bossier parishes. Public records connect STACK Infrastructure to the acquisitions through an LLC sharing its corporate ...

The Johns Hopkins University Data Science and AI Institute welcomes applications for its Postdoctoral Fellowship program, seeking disciplinarily diverse scholars to advance foundational methods of ...

A Colorado-based company, Stack Infrastructure, plans to build a new data center in New Albany, Ohio. The new 300,000-square-foot facility will be built next to the company's existing data center.

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...